Latest news
Latigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMTIs Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap As ADC Pipeline News Builds? - simplywall.stsimplywall.st · Thu, 06 Aug 2026 14:57:31 GMTWith $263M, LifeMine unearths a new drug for organ transplants - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 13:40:35 GMTCardiac drug developer Braveheart banks more than $382M in IPO - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 03:18:37 GMTAttovia adds to biotech IPO momentum with $289M offering - BioPharma DiveBioPharma Dive · Wed, 05 Aug 2026 16:19:45 GMTScottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 16:12:39 GMTOver 1/3 stay in biopharma jobs for health insurance, poll finds - BioSpaceBioSpace · Wed, 05 Aug 2026 14:51:22 GMTWhy China’s biotech rise is harder to contain than AI - ThinkChinaThinkChina · Wed, 05 Aug 2026 06:53:54 GMT